Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…
MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients
NEW DELHI, Oct. 9, 2025 /PRNewswire/ -- MSN Laboratories, a leading global…
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 29, 2025 19:15 ET Â | Source: Artelo Biosciences SOLANA BEACH, Calif.,…
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimers Disease Program
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to…
Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq:…
Renaissance Recovery Expands in Florida, Increasing Capacity and Improving Access to Addiction Treatment
In response to the growing need for addiction recovery services, Renaissance Recovery…
NYSE Content Advisory: Pre-Market Update + Retail Earnings Kick Off
NEW YORK, Aug. 19, 2025 /PRNewswire/ -- The New York Stock Exchange…